Axios International @Axiosint

More accurate affordability assessments lead to more sustainable access programs and better outcomes for patients. That’s the PFET difference. Learn more about Axios' means-based assessment tool: axiosint.com/access-to-trea… #WeFindaWay #MarketAccess #AccessToMedicines

A new Axios study analyzing data from 18,500+ cancer patients across 20 countries shows how access program data can help predict survival and treatment adherence. Predictive access solutions are the next frontier of healthcare access. Read more: ascopubs.org/doi/pdf/10.120…

Healthcare access doesn't happen on its own. It takes people who can solve problems, build systems, support patients, and keep programs running smoothly. We're growing our team and hiring for several exciting opportunities across our global organization: axiosint.com/healthcare-car…

We're proud to share that we've received an excellent result in our recent Information Security and Data Privacy Assessment conducted by CyberVadis. Protecting information entrusted to us is a responsibility we take seriously and critical to delivering access to treatment.

Today is #WorldMSDay. For 14 years across four countries in the Middle East, we've supported more than 1,000 people living with MS—helping them access treatment and stay on therapy. Today, we recognize the strength of patients, families, and caregivers navigating MS every day. 🧡

Earlier this month, Majdoline Mughari, Regional Operations Lead, attended #SIPHA26, the Saudi International Pharmaceutical Conference hosted by the Saudi Pharmaceutical Society. It was a valuable opportunity to exchange perspectives with partners shaping access across the region.

At #ISPORAnnual, much of the discussion focused on MFN pricing and its global implications. Our conversations on patient-level affordability in self-pay and LMIC markets offered a different perspective: access models must evolve to reflect patient reality.

Two patients may share the same diagnosis, but different financial realities. Axios’ Patient Financial Eligibility Tool helps determine what patients can realistically contribute toward treatment for more sustainable access solutions and better outcomes. ow.ly/kQI950Z08wR

Sustainable access in countries with large self-pay populations requires more than country-level insights. It requires understanding what patients can actually afford. If this challenge resonates with you, join us at #ISPOR2026 in Philadelphia next week.

Meet our India-based team supporting access programs across the country. Working across four regions and speaking seven languages, this dedicated team helps patients navigate every step of their treatment journey. Learn more: axiosint.com or [email protected].

Sustainable access strategies aren’t built on assumptions. Axios uses proprietary affordability and willingness tools to turn real-world insights into practical, patient-centered strategies that help patients access and complete treatment. Learn more: axiosint.com/access-strateg…

Great to be at the 2nd Emirates Thoracic Congress last week. Spent time with our partners at the Emirates Cancer Society discussing how we can continue to work together to improve access to care and treatment for #cancer patients in the UAE. #WeFindAWay

Our access programs share one goal: helping patients complete their full treatment, not just a few boxes. We design for continuity so patients don’t drop off early and miss out on full benefit. That's something to smile about. Learn more: axiosint.com/axios-access-s…

Rana’s journey at Axios has been more than a career. It’s been a perspective shift. One of the most powerful lessons she’s learned? The true value of time. While it can pass unnoticed for many, for the patients we serve, every second matters. #WeFindAWay #AccesstoHealthcare

Today is #WorldHealthDay—a reminder that health belongs to everyone, everywhere. At Axios, #WeFindAWay means making #PatientAccess possible, regardless of the medicine, country, or challenge.Learn how: axiosint.com/axios-access-s… #StandWithScience

A patient with a heart condition. A child with a rare immune disorder. Someone navigating a cancer diagnosis far from home. Over the last decade, Axios has enabled access to 225 medications across 11 therapeutic areas. Whatever the medicine. Whoever the patient. #WeFindAWay.

She didn’t say no. She just wasn’t ready. So Nageswari didn’t push. She listened and gave space. Until one day, the patient was ready. Because access isn’t just about affordability. It’s about feeling seen and supported. At Axios, #WeFindAWay through compassion.

Adherence isn’t just about taking a pill. It’s about creating the right support so patients can stay on treatment throughout their journey. Because every patient is different, our solutions are designed to meet real challenges with personalized support: axiosint.com/access-to-maxi…

Our team recently attended the Regional Oncology Conference organized by the Kuwait Society for Smoking and Cancer Prevention + the Gulf Federation for Cancer Control to discuss improving access to oncology treatment. More: axiosint.com/access-to-trea…

keyboard_arrow_left Previous keyboard_arrow_right Next

Since 1997, Axios has pioneered patient access — starting with the first antiretroviral access program at the height of the HIV/AIDS epidemic. Today, we’ve reached nearly 10 million people across 100+ countries: axiosint.com #NeverStandStill #AccesstoHealthcare